CHOP Expert Breaks Down Latest Hemophilia A Gene Therapy Data
Published on in CHOP News
CHOP gene therapy expert Dr. Lindsey George reacts to a phase 3 hemophilia gene therapy study in an editorial in the New England Journal of Medicine.
Division of Hematology News and Updates
1 - 10 of 63
Novel Therapeutics for Bleeding Disorders (NoT Bleeding) Program
Published on in Children's Doctor
The Novel Therapeutics for Bleeding Disorders (NoT Bleeding) Program is a Children’s Hospital of Philadelphia (CHOP) Frontier Program within the Division of Hematology that aims to provide advanced clinical care of inherited bleeding disorders and develop breakthrough treatments through research.
NoT Bleeding Program Has Strong Presence at Premier Hematology Conference
Published on in CHOP News
CHOP experts in bleeding disorders care and research presented at the American Society of Hematology 2022 conference.
ASH 2022: CHOP Experts Presented and Contributed to More than 200 Abstracts at National Hematology Conference
Published on in CHOP News
Nearly 50 faculty, staff and trainees from the Division of Hematology and Division of Oncology at Children’s Hospital of Philadelphia attended the 64th Annual American Hematology Society (ASH) Meeting in New Orleans, Louisiana.
Dr. Alexis Thompson Discusses Early Successes of Gene Therapy for Sickle Cell Disease
Published on in CHOP News
In a short documentary by the New England Journal of Medicine, Dr. Alexis Thompson discusses the early successes of gene therapy, as well as its risks and benefits.
FDA Approves First Potentially Curative Gene Therapy for Beta Thalassemia
Published on in CHOP News
A leading study site for nearly a decade, CHOP will be part of a network of treatment centers in the country offering the therapy to patients who require regular blood transfusions.
CHOP Researchers Refine Understanding of Fetal Hemoglobin Regulation
Published on in CHOP News
CHOP researchers have discovered a new part of the regulatory cascade responsible for silencing fetal hemoglobin in adult cells.
New Data Show Benefits of CRISPR-edited Gene Therapy for Blood Disorders in a Larger Patient Group with Longer-Term Follow-Up
Published on in CHOP News
A group of researchers that includes CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.
CHOP Researchers Identify Novel Factors Involved in Silencing Fetal Hemoglobin
Published on in CHOP News, Cardiac Center Provider Updates
CHOP researchers have identified two transcription factors that are involved in silencing fetal hemoglobin in adult red blood cells.
Children’s Hospital of Philadelphia Awards Gold Medal to Dr. Katherine High, Gene Therapy Pioneer
Published on in CHOP News
Prestigious award recognizes Dr. High’s contribution to improving children’s health through her gene therapy research, which began during her time at CHOP.